AKT1 and diffuse large B-cell lymphoma: Its role in tumorigenesis and disease progression has been associated to the inhibition of the expression of phosphatases, limiting the activity of signaling pathways such as PI3K/AKT, recently suggested to play a crucial role in mediating growth, proliferation and cell survival in a substantial number of DLBCL patients [42, 43].